Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Barbara Seitz-Polski

Showing results (31-40 of 78) with videos related to

Pageof 8
Sort By:
Transplantation Proceedings|January 1, 2020
Monitoring of CMV-Specific Cell-Mediated Immunity in Kidney Transplant Recipients With a High Risk of CMV Disease (D+/R-): A Case SeriesMarine Andreani, Laetitia Albano, Sylvia Benzaken, et al.
Neurotherapeutics : the Journal of the American Society for Experimental Neurotherapeutics|March 26, 2021
Memory B Cells Predict Relapse in Rituximab-Treated Myasthenia GravisCaroline Ruetsch-Chelli, Saskia Bresch, Barbara Seitz-Polski, et al.
Frontiers in Immunology|March 23, 2023
Immune response to BNT162b2 SARS-CoV-2 vaccine in patients living with HIV: The COVIH-DAPT studySabrina Manni, Caroline Ruetsch, Roxane Fabre, et al.
Journal of Clinical Immunology|August 22, 2023
Both Humoral and Cellular Immune Responses to SARS-CoV-2 Are Essential to Prevent Infection: a Prospective Study in a Working Vaccinated Population from Southern FranceDaisy Graça, Vesna Brglez, Jonathan Allouche, et al.
Clinical Journal of the American Society of Nephrology : CJASN|March 21, 2023
Risk Factors Associated with the Occurrence of Anti-rituximab Antibodies in Membranous NephropathyMaxime Teisseyre, Vesna Brglez, Marion Cremoni, et al.
Food and Chemical Toxicology : an International Journal Published for the British Industrial Biological Research Association|June 16, 2023
Letter to Editor "Innate immune suppression by SARS-CoV-2 mRNA vaccinations: The role of G-quadruplexes, exosomes, and MicroRNAs": Important concerns on the validity of this articleJérôme Barrière, Fabrice Frank, Lonni Besancon, et al.
Frontiers in Medicine|October 17, 2022
Untargeted plasma metabolomic fingerprinting highlights several biomarkers for the diagnosis and prognosis of coronavirus disease 19Céline Occelli, Jean-Marie Guigonis, Sabine Lindenthal, et al.
American Journal of Nephrology|April 4, 2013
Patients' preferences regarding choice of end-stage renal disease treatment optionsAbdelmouttalib Maaroufi, Coraline Fafin, Sophie Mougel, et al.
Frontiers in Immunology|January 31, 2020
Neutralizing Anti-Rituximab Antibodies and Relapse in Membranous Nephropathy Treated With RituximabSonia Boyer-Suavet, Marine Andreani, Maël Lateb, et al.
Journal of the Neurological Sciences|August 20, 2016
Interleukin 17 alone is not a discriminant biomarker in early demyelinating spectrum disordersChristine Lebrun, Mikael Cohen, Beatrice Pignolet, et al.
Pageof 8

Showing results (31-40 of 78) with videos related to

Sort By:
Pageof 8
Transplantation Proceedings|January 1, 2020
Monitoring of CMV-Specific Cell-Mediated Immunity in Kidney Transplant Recipients With a High Risk of CMV Disease (D+/R-): A Case SeriesMarine Andreani, Laetitia Albano, Sylvia Benzaken, et al.
Neurotherapeutics : the Journal of the American Society for Experimental Neurotherapeutics|March 26, 2021
Memory B Cells Predict Relapse in Rituximab-Treated Myasthenia GravisCaroline Ruetsch-Chelli, Saskia Bresch, Barbara Seitz-Polski, et al.
Frontiers in Immunology|March 23, 2023
Immune response to BNT162b2 SARS-CoV-2 vaccine in patients living with HIV: The COVIH-DAPT studySabrina Manni, Caroline Ruetsch, Roxane Fabre, et al.
Journal of Clinical Immunology|August 22, 2023
Both Humoral and Cellular Immune Responses to SARS-CoV-2 Are Essential to Prevent Infection: a Prospective Study in a Working Vaccinated Population from Southern FranceDaisy Graça, Vesna Brglez, Jonathan Allouche, et al.
Clinical Journal of the American Society of Nephrology : CJASN|March 21, 2023
Risk Factors Associated with the Occurrence of Anti-rituximab Antibodies in Membranous NephropathyMaxime Teisseyre, Vesna Brglez, Marion Cremoni, et al.
Food and Chemical Toxicology : an International Journal Published for the British Industrial Biological Research Association|June 16, 2023
Letter to Editor "Innate immune suppression by SARS-CoV-2 mRNA vaccinations: The role of G-quadruplexes, exosomes, and MicroRNAs": Important concerns on the validity of this articleJérôme Barrière, Fabrice Frank, Lonni Besancon, et al.
Frontiers in Medicine|October 17, 2022
Untargeted plasma metabolomic fingerprinting highlights several biomarkers for the diagnosis and prognosis of coronavirus disease 19Céline Occelli, Jean-Marie Guigonis, Sabine Lindenthal, et al.
American Journal of Nephrology|April 4, 2013
Patients' preferences regarding choice of end-stage renal disease treatment optionsAbdelmouttalib Maaroufi, Coraline Fafin, Sophie Mougel, et al.
Frontiers in Immunology|January 31, 2020
Neutralizing Anti-Rituximab Antibodies and Relapse in Membranous Nephropathy Treated With RituximabSonia Boyer-Suavet, Marine Andreani, Maël Lateb, et al.
Journal of the Neurological Sciences|August 20, 2016
Interleukin 17 alone is not a discriminant biomarker in early demyelinating spectrum disordersChristine Lebrun, Mikael Cohen, Beatrice Pignolet, et al.
Pageof 8